However, Nifty's move towards 24,200 would not be in a linear manner as bouts of volatility in the backdrop of looming US ...

Piramal believes that while passing the baton of the group's business, it is crucial for leaders—especially those accustomed ...

Werner Cautreels, PhD, to retire as CEO, while continuing as a Board MemberIain D. Dukes, D Phil, Executive Board Chairman, to become Interim ...

With President Donald Trump expected to levy tariffs on pharmaceuticals manufactured outside the United States, industry ...

Milestone in 2023 agreed to sell a royalty interest in etripamil to RTW Investments for $75 million, subject to the company receiving FDA approval of the drug by the end of September 2025. Write to ...

Tracey Ryniec, Zacks Senior Stock Strategist, and Mark Zinski, Zacks Senior Microcap Research Analyst, discuss two of Mark's ...

UTC+8Record-Breaking Revenue of HK$553.0M and Net Profit of HK$82.8MFirst-ever Dividend was HK$0.277 Cents Per Share Strengthening Presence in Osteoporosis, Ophthalmology, and Aesthetic Medical ...

Around XX percent equity of JB Chemicals changed hands in a block deal, at a premium/discount to the previous session's ...

JP Morgan's survey of endocrinologists finds strong awareness of Crinetics' atumelnant, with positive efficacy impressions.

Pharmaceutical warehousing is not just about storing products; it’s a critical part of the supply chain that ensures the ...

Mira Pharmaceuticals is making moves in weight loss and smoking cessation. The biotech is trying to buy Skny Pharmaceuticals ...

The U.S. Health and Human Services Department is weighing plans to drastically cut federal government funding for domestic ...